359 related articles for article (PubMed ID: 16690904)
1. Highly efficient gluten degradation with a newly identified prolyl endoprotease: implications for celiac disease.
Stepniak D; Spaenij-Dekking L; Mitea C; Moester M; de Ru A; Baak-Pablo R; van Veelen P; Edens L; Koning F
Am J Physiol Gastrointest Liver Physiol; 2006 Oct; 291(4):G621-9. PubMed ID: 16690904
[TBL] [Abstract][Full Text] [Related]
2. Efficient degradation of gluten by a prolyl endoprotease in a gastrointestinal model: implications for coeliac disease.
Mitea C; Havenaar R; Drijfhout JW; Edens L; Dekking L; Koning F
Gut; 2008 Jan; 57(1):25-32. PubMed ID: 17494108
[TBL] [Abstract][Full Text] [Related]
3. Combination enzyme therapy for gastric digestion of dietary gluten in patients with celiac sprue.
Gass J; Bethune MT; Siegel M; Spencer A; Khosla C
Gastroenterology; 2007 Aug; 133(2):472-80. PubMed ID: 17681168
[TBL] [Abstract][Full Text] [Related]
4. Influence of dietary components on Aspergillus niger prolyl endoprotease mediated gluten degradation.
Montserrat V; Bruins MJ; Edens L; Koning F
Food Chem; 2015 May; 174():440-5. PubMed ID: 25529703
[TBL] [Abstract][Full Text] [Related]
5. Fermentation, purification, formulation, and pharmacological evaluation of a prolyl endopeptidase from Myxococcus xanthus: implications for Celiac Sprue therapy.
Gass J; Ehren J; Strohmeier G; Isaacs I; Khosla C
Biotechnol Bioeng; 2005 Dec; 92(6):674-84. PubMed ID: 16136593
[TBL] [Abstract][Full Text] [Related]
6. Prolyl endopeptidase-mediated destruction of T cell epitopes in whole gluten: chemical and immunological characterization.
Marti T; Molberg O; Li Q; Gray GM; Khosla C; Sollid LM
J Pharmacol Exp Ther; 2005 Jan; 312(1):19-26. PubMed ID: 15358813
[TBL] [Abstract][Full Text] [Related]
7. A randomised, double-blind, cross-over trial to evaluate bread, in which gluten has been pre-digested by prolyl endoprotease treatment, in subjects self-reporting benefits of adopting a gluten-free or low-gluten diet.
Rees D; Holtrop G; Chope G; Moar KM; Cruickshank M; Hoggard N
Br J Nutr; 2018 Mar; 119(5):496-506. PubMed ID: 29508689
[TBL] [Abstract][Full Text] [Related]
8. Consumption of gluten with gluten-degrading enzyme by celiac patients: a pilot-study.
Tack GJ; van de Water JM; Bruins MJ; Kooy-Winkelaar EM; van Bergen J; Bonnet P; Vreugdenhil AC; Korponay-Szabo I; Edens L; von Blomberg BM; Schreurs MW; Mulder CJ; Koning F
World J Gastroenterol; 2013 Sep; 19(35):5837-47. PubMed ID: 24124328
[TBL] [Abstract][Full Text] [Related]
9. Extracellular prolyl endoprotease from Aspergillus niger and its use in the debittering of protein hydrolysates.
Edens L; Dekker P; van der Hoeven R; Deen F; de Roos A; Floris R
J Agric Food Chem; 2005 Oct; 53(20):7950-7. PubMed ID: 16190655
[TBL] [Abstract][Full Text] [Related]
10. Identification of N-glycosylation in prolyl endoprotease from Aspergillus niger and evaluation of the enzyme for its possible application in proteomics.
Sebela M; Rehulka P; Kábrt J; Rehulková H; Ozdian T; Raus M; Franc V; Chmelík J
J Mass Spectrom; 2009 Nov; 44(11):1587-95. PubMed ID: 19757411
[TBL] [Abstract][Full Text] [Related]
11. Treatment of both native and deamidated gluten peptides with an endo-peptidase from Aspergillus niger prevents stimulation of gut-derived gluten-reactive T cells from either children or adults with celiac disease.
Toft-Hansen H; Rasmussen KS; Staal A; Roggen EL; Sollid LM; Lillevang ST; Barington T; Husby S
Clin Immunol; 2014 Aug; 153(2):323-31. PubMed ID: 24905137
[TBL] [Abstract][Full Text] [Related]
12. A new microbial gluten-degrading prolyl endopeptidase: Potential application in celiac disease to reduce gluten immunogenic peptides.
Moreno Amador ML; Arévalo-Rodríguez M; Durán EM; Martínez Reyes JC; Sousa Martín C
PLoS One; 2019; 14(6):e0218346. PubMed ID: 31246975
[TBL] [Abstract][Full Text] [Related]
13. Effect of barley endoprotease EP-B2 on gluten digestion in the intact rat.
Gass J; Vora H; Bethune MT; Gray GM; Khosla C
J Pharmacol Exp Ther; 2006 Sep; 318(3):1178-86. PubMed ID: 16757540
[TBL] [Abstract][Full Text] [Related]
14. A quantitative analysis of transglutaminase 2-mediated deamidation of gluten peptides: implications for the T-cell response in celiac disease.
Dørum S; Qiao SW; Sollid LM; Fleckenstein B
J Proteome Res; 2009 Apr; 8(4):1748-55. PubMed ID: 19239248
[TBL] [Abstract][Full Text] [Related]
15. Production of the prolyl endoprotease (PEP) from Aspergillus sp. FSDE 16 by solid-state fermentation (SSF) and use for producing a gluten-free beer.
Almeida TC; Santos SFM; Santos ESD
Biotechnol Appl Biochem; 2024 Apr; 71(2):460-476. PubMed ID: 38212282
[TBL] [Abstract][Full Text] [Related]
16. Randomized clinical trial: Effective gluten degradation by Aspergillus niger-derived enzyme in a complex meal setting.
König J; Holster S; Bruins MJ; Brummer RJ
Sci Rep; 2017 Oct; 7(1):13100. PubMed ID: 29026170
[TBL] [Abstract][Full Text] [Related]
17. Rational design of combination enzyme therapy for celiac sprue.
Siegel M; Bethune MT; Gass J; Ehren J; Xia J; Johannsen A; Stuge TB; Gray GM; Lee PP; Khosla C
Chem Biol; 2006 Jun; 13(6):649-58. PubMed ID: 16793522
[TBL] [Abstract][Full Text] [Related]
18. Discovery, cloning and characterisation of proline specific prolyl endopeptidase, a gluten degrading thermo-stable enzyme from Sphaerobacter thermophiles.
Shetty R; Vestergaard M; Jessen F; Hägglund P; Knorr V; Koehler P; Prakash HS; Hobley TJ
Enzyme Microb Technol; 2017 Dec; 107():57-63. PubMed ID: 28899487
[TBL] [Abstract][Full Text] [Related]
19. Future therapeutic options for celiac disease.
Sollid LM; Khosla C
Nat Clin Pract Gastroenterol Hepatol; 2005 Mar; 2(3):140-7. PubMed ID: 16265155
[TBL] [Abstract][Full Text] [Related]
20. Highly efficient gluten degradation by lactobacilli and fungal proteases during food processing: new perspectives for celiac disease.
Rizzello CG; De Angelis M; Di Cagno R; Camarca A; Silano M; Losito I; De Vincenzi M; De Bari MD; Palmisano F; Maurano F; Gianfrani C; Gobbetti M
Appl Environ Microbiol; 2007 Jul; 73(14):4499-507. PubMed ID: 17513580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
